GR-46611
Pharmaceutical compound
From Wikipedia, the free encyclopedia
GR-46611 is a non-selective serotonin 5-HT1 receptor agonist of the triptan group which has been used in scientific research.[1][2][3][4] It is specifically an agonist of the serotonin 5-HT1A, 5-HT1B, and 5-HT1D receptors.[4] The drug's affinities (Ki) are 1.3 nM for the serotonin 5-HT1A receptor, 0.1 to 1.3 nM for the serotonin 5-HT1B receptor, and 0.2 to 1.0 nM for the serotonin 5-HT1D receptor.[3][4][5] Conversely, it showed very weak affinity for the serotonin 5-HT2A receptor (Ki = 1,000 nM).[4] The drug does not alter or stimulate locomotor activity when given alone in rodents, but does potentiate the hyperlocomotion induced by the serotonin 5-HT1A receptor agonists 8-OH-DPAT and buspirone.[2] The chemical synthesis of GR-46611 has been described.[3] GR-46611 was first described in the scientific literature by 1994.[6]
- None
| Clinical data | |
|---|---|
| Other names | GR46611 |
| Drug class | Serotonin 5-HT1 receptor agonist; Serotonin 5-HT1A receptor agonist; Serotonin 5-HT1B receptor agonist; Serotonin 5-HT1D receptor agonist |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEBI | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C23H27N3O2 |
| Molar mass | 377.488 g·mol−1 |
| 3D model (JSmol) | |
| |
| |